Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-01-004614
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
5
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS g67891e10-k.txt 10-K 388540
2 FOURTH AMENDMENT TO CREDIT AGREEMENT g67891ex10-3.txt EX-10.3 11641
3 SUBSIDIARIES OF THE REGISTRANT g67891ex21-1.txt EX-21.1 644
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP g67891ex23-1.txt EX-23.1 564
5 CONSENT OF ERNST & YOUNG g67891ex23-2.txt EX-23.2 877
  Complete submission text file 0000950144-01-004614.txt   404227
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 1590515
SIC: 2834 Pharmaceutical Preparations